Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001960048-26-000015

SVP, Finance & CAO sold 3,000 shares at an average $60.92 ($182,753)

  • SVP, Finance & CAO acquired 3,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cowan Elvia · SVP, Finance & CAO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-02 Exercise or conversion : show line 1 in the form 10b5-1 +3,000 $25.92 $77,760 30,860 D
2026-11-02 Sale : show line 2 in the form 10b5-1 −2,414 $60.77 $146,687 28,446 D
2026-11-02 Sale : show line 3 in the form 10b5-1 −586 $61.55 $36,067 27,860 D
Open-market sales · 3,000 sh · avg $60.92 · $182,753

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-02 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −3,000 71,068 D
Loading xslF345X06/wk-form4_1793829138.xml…